LSV Asset Management
EW icon

LSV Asset Management’s Edwards Lifesciences EW Stock Holding History

LSV Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,705
Closed -$412K – 944
2019
Q2 		$412K Hold
6,705
– – ﹤0.01% 839
2019
Q1 		$427K Hold
6,705
– – ﹤0.01% 848
2018
Q4 		$342K Hold
6,705
– – ﹤0.01% 876
2018
Q3 		$389K Buy
+6,705
New +$328K ﹤0.01% 889

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

LSV Asset Management's EW Position: Q3 2019 in Review

LSV Asset Management sold out of Edwards Lifesciences (EW) in Q3 2019, closing a stake of 6,705 shares — an estimated $412K sold.

LSV Asset Management first reported a position in EW in Q3 2018 and held it in 4 quarters. The position peaked at $427K in Q1 2019. 965 funds tracked by Wall St. Rank hold EW as of Q3 2019.

  • LSV Asset Management reported no remaining Edwards Lifesciences position as of Q3 2019 after selling out during the quarter.
  • LSV Asset Management sold 6,705 Edwards Lifesciences shares in Q3 2019, an estimated $412K.
  • LSV Asset Management first reported a position in Edwards Lifesciences in Q3 2018 and held it in 4 quarters.
  • LSV Asset Management's Edwards Lifesciences position peaked at $427K in Q1 2019.
  • 965 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on LSV Asset Management's 13F filing for Q3 2019, filed 7 Nov 2019.